Autoantibodies to each protein fraction extracted from cerebral endothelial cell membrane in the sera of patients with multiple sclerosis
- PMID: 2478577
- DOI: 10.1016/0165-5728(89)90096-9
Autoantibodies to each protein fraction extracted from cerebral endothelial cell membrane in the sera of patients with multiple sclerosis
Abstract
Damage to the blood-brain barrier (BBB) occurs in multiple sclerosis (MS), probably due to an immunological mechanism. Anti-endothelial cell antibodies may play a pathogenetic role in the BBB damage. Our previous studies led us to search for which protein fraction extracted from cerebral endothelial cell membrane was reactive to antibodies in the sera of patients with MS. The antibodies to each protein fraction extracted from the rat cerebral endothelial cell membrane were studied in patients with MS, other neurological diseases and controls using an enzyme-linked immunosorbent assay (ELISA) method. The patients with active relapsing MS (P less than 0.01) displayed significantly higher levels of immunoglobulin G (IgG) binding to the endothelial cell membrane fraction than did the controls. The sera of the same patients (P less than 0.001) also showed significantly higher levels of antibodies to fraction I (8.0 kDa) than did the normal controls. The high levels of IgG binding to fraction II (11.0 kDa) and III (12.3 kDa) were significantly increased in the sera of patients with active relapsing MS compared to normal controls (P less than 0.01). The immune response to the protein fraction extracted from the cerebral endothelial cell membrane fraction may indicate a result of the BBB damage in the case of MS.
Similar articles
-
Anti-endothelial cell antibodies and circulating immune complexes in the sera of patients with multiple sclerosis.J Neuroimmunol. 1987 Dec;17(1):49-59. doi: 10.1016/0165-5728(87)90030-0. J Neuroimmunol. 1987. PMID: 2445776
-
Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.Brain. 1999 Nov;122 ( Pt 11):2047-56. doi: 10.1093/brain/122.11.2047. Brain. 1999. PMID: 10545390 Clinical Trial.
-
Relative frequency of autoantibodies to myelin basic protein and proteolipid protein in optic neuritis and multiple sclerosis cerebrospinal fluid.J Neurol Sci. 1994 Jan;121(1):66-73. doi: 10.1016/0022-510x(94)90158-9. J Neurol Sci. 1994. PMID: 7510787
-
CSF antibodies to myelin basic protein and to myelin-associated glycoprotein in multiple sclerosis. Evidence of the intrathecal production of antibodies.Acta Neurol Scand. 1983 Nov;68(5):337-43. doi: 10.1111/j.1600-0404.1983.tb04841.x. Acta Neurol Scand. 1983. PMID: 6198864 Review.
-
Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis.J Neurol Sci. 2003 Jan 15;206(1):7-16. doi: 10.1016/s0022-510x(02)00349-0. J Neurol Sci. 2003. PMID: 12480078 Review.
Cited by
-
Antiphospholipid antibodies: paradigm in transition.J Neuroinflammation. 2009 Jan 20;6:3. doi: 10.1186/1742-2094-6-3. J Neuroinflammation. 2009. PMID: 19154576 Free PMC article. Review.
-
Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):281-6. doi: 10.1073/pnas.0509849103. Epub 2005 Dec 30. Proc Natl Acad Sci U S A. 2006. PMID: 16387849 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical